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Abstract 
Background: No specific scale to measure Quality of Life in Alzheimer’s Disease in Nursing Homes (QoL-AD NH) 
exists in French. We aimed to translate and culturally adapt the QoL-AD NH participant scale into a French version and 
evaluate its psychometric properties with residents in French nursing homes (EHPAD).
Methods: First, the QoL-AD NH was cross-culturally adapted into French according to guidelines. Secondly, a con-
venience group of residents with mild to moderate dementia answered the Folstein’s test and the QoL-AD NH. They 
also answered the Dementia Quality of Life and the Geriatric Depression Scale to test convergent and divergent valid-
ity. Known-group validity was tested with a comparison group of residents without dementia. Exploratory Structural 
Equation Modeling (ESEM) was used after Exploratory Factor Analysis (EFA) to identify factors and measure invariance 
across age and mental state groups. Reliability (internal consistency, McDonald’s omega and test–retest) were also 
measured.
Results: Following successful adaptation of the QoL-AD NH, 174 residents (mean age 86.6) from 7 nursing homes 
with mild to moderate dementia participated in the validation study. We retained a 3-factor model of the scale after 
ESEM identifying: “Intra & interpersonal environment-related QoL”, “Self-functioning-related QoL” and “Perceived cur-
rent health-related QoL” that were invariant across age and mental state groups. The QoL-AD NH had acceptable 
convergent (ρ range 0.24–0.53) and divergent validity (ρ range − 0.43 to − 0.57) and good known-group validity with 
33 residents without dementia (t(205) = 2.70, p = .007). For reliability, the results revealed very good and adequate 
internal consistency (α = 0.86 for total scale and ≥ 0.71 for subscales). All total omega values exceeded the threshold 
0.70. The hierarchical omega was 0.50, supporting the multidimensionality of the scale. Hierarchical omega subscale 
values exceeded the minimal level 0.50 except for the third factor, although reliable, would deserve more items. Test–
retest was good with ICC (3,1) = 0.76.
Conclusions: The QoL-AD NH French participant version has globally good reliability and validity for evaluating resi-
dents’ quality of life. However, further studies must rework and confirm the factor structure, test sensitivity to change 
and responsiveness.
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Background
In France, nursing homes for elderly (EHPAD—Établisse-
ment d’Hébergement pour Personnes âgées Dépendantes) 
are accommodating increasingly older residents with 
chronic illnesses and major cognitive impairments. More 
than 70% of EHPAD residents can have major cognitive 
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impairments [1–3]. Knowing that the average length of 
stay of a resident in a nursing home is 3.6 years [4], eval-
uating and improving quality of life in nursing homes is 
a critical societal issue. In this way, the French National 
Agency for the Evaluation and Quality of Social and 
Medico-social Establishments and Services (ANESM) 
has included an approach focused on Quality of life in 
EHPAD in its work program [5]. In strand 1 of this pro-
gram, the ANESM declares (p. 7):
An EHPAD is a place where the aim is the quality of 
life of each resident throughout their stay, whatever 
their difficulties: physical dependence, loss of deci-
sion-making autonomy, or difficulties in expressing 
themselves.
The concept of quality of life (QoL) has been conceptu-
alised and defined differently, making it difficult to meas-
ure. In 1994, the World Health Organization defined QoL 
as:
An individual’s perceptions of their position in life in 
the context of the culture and value systems in which 
they live, and in relation to their goals, expectations, 
standards and concerns.
In the context of elderly cognitive impairment, there is 
emerging agreement on the meaning of QoL [6–8]. Law-
ton’s model is the most widely used conceptualisation 
of QoL in Alzheimer’s disease (and related disorders), 
including both objective and subjective factors based on 
four fundamental dimensions: “Psychological well-being” 
(e.g., positive and negative affects), “Behavioural skills” 
(e.g., cognitive and functional abilities), “Objective envi-
ronment” (caregivers, helpers and living situation) and 
“Perceived QoL” [9]. According to this model, self-report 
would be preferable when feasible, and proxy-reports 
would occur when not feasible. However, a recent sys-
tematic study advocated the use of a proxy observation 
tool, the QUALIDEM, to assess the QoL of residents with 
cognitive impairments [10], although families and car-
egivers have been reported to undervalue the QoL of the 
person with cognitive impairment [11–15]. Nevertheless, 
despite the presence of cognitive impairment, many stud-
ies have shown that patients with Alzheimer’s disease 
were fully able to assess their QoL [11, 16–18], even up to 
an advanced disease stage [12, 19–21].
Over the past twenty-five years, researchers have devel-
oped many scales to assess HRQoL specific to dementia, 
yet there is not yet a gold standard to measure QoL in 
Azheimer’s disease [14, 22]. One scale, widely used in 
studies, is the QoL in Alzheimer’s Disease scale (QoL-
AD 13) [23–25]. This scale is available in many Euro-
pean countries after cross-cultural adaptations [26–30], 
including France [31]. However, this scale may not be 
optimal for assessing QoL of residents who live in institu-
tions as some items are specific to assess QoL at home. 
That is why Edelman et al. [13] slightly modified this tool 
to measure more precisely QoL in Alzheimer’s disease 
in elderly institutions/nursing homes with participant 
and proxy versions. While some researchers have used 
the QoL-AD NH scale in both versions (self and proxy-
rated) [11–14, 32] or self-rated version only [33], others 
have only focused on proxy evaluation [15, 34–37] like 
Edelman et al. [13] who used the QoL-AD NH in a proxy 
evaluation with staff for the first time.
Several recent systematic reviews have emphasised 
weak or unexplored psychometric properties of demen-
tia-specific QoL instruments for use in care settings, 
including the QoL-AD NH [10, 22, 24, 38]. Indeed, 
almost all studies have used the QoL-AD NH as an out-
come measure but have never tested psychometric prop-
erties of the participant’s version. Only two studies have 
examined dimensionality of the QoL-AD NH, using only 
11 items out of 15 on the scale [27, 39]. As a result, the 
QoL-AD NH scale has not yet shown real psychometric 
qualities, even in its original English version since there is 
no psychometric validation study. Finally, while there are 
scales that assess the HRQoL among community-dwell-
ing older people in France [31, 40], there is, to our knowl-
edge, no specific self-rating scale to assess residents’ QoL 
in Alzheimer’s disease in France, and more globally in the 
French-speaking world.
Our research aimed to provide a French cross-cul-
tural adaptation and a first psychometric validation of 
the QoL-AD NH Participant version for French nursing 
home residents with mild to moderate Alzheimer’s dis-
ease or related disorders.
Methods
Study design
We led a descriptive cross-sectional study in two phases. 
In phase 1, the translation and cross-cultural adaptation 
of the QoL-AD NH (Participant version during an inter-
view) from English into French was undertaken. In phase 
II, psychometric validation of the French adaptation was 
performed.
Ethical approval was obtained from the CERNI Eth-
ics Committee of the University of Toulouse (number 
2017-064).
Phase 1: Translation and cross‑cultural (transcultural) 
adaptation of the QoL‑AD NH participant version
According to cross-cultural adaptation guidelines, a 
French adaptation was carried out, which involves 
adaptation, not just translation [41]. Several steps were 
necessary.
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Translation (from English to French)
First of all, two French native-speaking translators inde-
pendently translated the original English version of the 
QoL-AD NH; one of the translators (T1) was familiar 
with the study’s concepts and the medical environment, 
the other (T2) was not.
Synthesis
A synthesis of the two translations was carried out, and a 
consensus was reached to develop a T-12 version.
Back translation (from French to English)
Working from the T-12 version of the scale, two English 
mother-tongue translators who were naive to the con-
cepts and the medical environment carried out the back 
translation and produced B1 and B2 versions.
Expert committee review
After the translations, an expert committee met with the 
four translators, the principal investigator (CC) and the 
two co-authors (BQ, VI); the first one was specialised in 
QoL, the other in gerontology. This expert committee 
produced a pre-final version of the scale. The role was to 
consolidate all the translated versions considering four 
aspects: (1) semantic equivalence, (2) idiomatic equiva-
lence, (3) experiential equivalence, and (4) conceptual 
equivalence.
Pretesting
The aim was to individually test the comprehension of 
the items and instructions of the adapted interview guide 
as well as the understanding and clarity of the response 
system. Ultimately, the aim was to assess the extent to 
which residents with mild to moderate cognitive impair-
ment could complete the questionnaire according to the 
instructions and the proposed response system before 
use in the psychometric validation study.
Both Rebecca Logsdon (the original author and who 
participated in this French adaptation) and Perry Edel-
man (the lead author of the English nursing home adapta-
tion) approved our cross-cultural adaptation into French.
Phase 2: Psychometric validation of the QoL‑AD NH French 
Participant version
Participants
Participants were residents of several nursing homes 
from the southwest of France.
They were recruited in two convenience samples 
according to different inclusion and exclusion criteria.
Inclusion criteria for the main sample were:
• To be at least 60  years old and a native French 
speaker
• To be a resident in the nursing home for more than 
three months
• To have a major neurocognitive disorder from mild 
to moderate stage
• To have a Mini-Mental State Examination (MMSE) 
score ≥ of 10
Exclusion criteria for the main sample were:
• Residents with major hearing or visual impairments 
despite the correction
• Residents hospitalised in the 30 days before the inter-
view
• Residents with excessive cognitive-behavioural prob-
lems precluding answering the questions.
A comparison group of residents without cognitive 
impairment was also recruited. Criteria for non-cognitive 
impairment were confirmed by taking age and education 
into account in the MMSE score [42] and with the study 
group’s first two inclusion/exclusion criteria.
The main sample size was based on the recommenda-
tions proposed by the Consensus-based Standards for 
the Selection of Health Measurement Instruments (COS-
MIN) to have at least five to ten times more participants 
per item of the questionnaire [43]. For this purpose and 
security purposes, the minimum estimated sample was 
150. The sample size for the comparison group was set 
at a minimum of 30 participants and 25 participants for 
test–retest reliability (randomly extracted from the main 
group).
Questionnaires
A sociodemographic questionnaire indicated gender, age, 
education level, family situation, type of dementia, and 
dependency level, from GIR 6 (complete autonomy) to 
GIR 1 (totally dependent). This information was collected 
from the residents’ medical records. Moreover, we noted 
any possible legal protection measure.
The protocol administered included the following 
questionnaires:
The Mini-Mental State Examination (MMSE) [44]
 This scale assesses cognitive abilities, from no 
cognitive impairment to very severe cognitive impair-
ment [45]. We used the GRECO version adapted and 
calibrated in French [42, 46]. In the absence of evi-
dence to determine an MMSE cut-off score between 
mild and moderate cognitive impairment, two groups 
were created for comparison, taking as cut-off value 
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the median of the MMSE scores [27]. Scores can 
range from 0 to 30 (higher scores indicating better 
cognitive status). MMSE scores were obtained either 
from the nursing home tests if run less than three 
months ago or as part of the study protocol. We did 
this to include residents in the right group according 
to their most current cognitive score.
The QoL in Alzheimer’s Disease Nursing Home 
(QoL-AD NH) participant version
 The QoL-AD NH is an adaptation of Logsdon et al.’s 
[23] QoL-AD scale. The QoL-AD scale was adapted 
to QoL-AD NH [13] to assess the QoL in Alzhei-
mer’s disease for residents in nursing homes. We 
used the adapted “Participant version” run directly 
with the resident answering questions during an 
interview. According to the original author of the 
QoL-AD 13 [23] and the QoL-AD NH [13], patients 
with an MMSE score ≥ 10 can complete the ques-
tionnaire. The scale includes 15 items rating from 
1 to 4 points each: 1 (Poor); 2 (Fair); 3 (Good); 4 
(Excellent) and total scores ranging from 15 to 60. 
Questionnaires with a maximum of two missing 
items were considered valid.
Dementia Quality of Life (DQoL)
 The Dementia QoL (DQoL) scale was validated in 
English with a sample of 99 patients with dementia 
[16] and was adapted into French with elderly peo-
ple with mild to moderate dementia [47]. This tool 
measures the construct of perceived QoL in Alzhei-
mer’s disease of the elderly. It consists of 29 items 
on a 5-level Likert scale and covers five factors: (1) 
“Self-esteem” (2) “Positive affect/Humor” (3) “Nega-
tive affect” (4) “Feelings of belonging” (5) “Sense of 
Aesthetics”. A final optional item assessing the over-
all QoL was not used in this study. An average score 
was calculated for each DQoL dimension. This scale 
was recommended by a systematic review to assess 
QoL of residents with cognitive impairments [48]. 
So, we chose this scale to test convergent validity.
The Geriatric Depression 15-item Scale (GDS-15)
 The GDS-15 assesses depressive complaints and the 
intensity of depression in the elderly [49, 50]. This 
scale validated in French [51] was well suited to older 
people without cognitive impairment and older peo-
ple with mild to moderate cognitive impairment 
[52]. GDS-15 is rated yes/no. The minimum score is 
0, and the maximum is 15. The higher the score, the 
more depressive symptoms and intensity are present. 
We chose this scale to test divergent validity.
Data collection
Twenty-one nursing homes (EHPAD) in France’s south-
ern Aquitaine region were initially contacted by phone 
to interview nursing home residents. The initial contact 
was often made with the psychologist of the EHPAD, 
who informed the nursing home director of the study and 
requested their participation. We clearly explained that the 
study only evaluated the perceived (and therefore subjec-
tive) resident’s QoL and not the care or facility’s quality.
When the structures agreed, nursing home man-
agement initially informed residents and families that 
research would be conducted within the facility on the 
QoL of EHPAD residents. Taking into account potential 
participant vulnerability, we obtained the agreement of 
the curator when the resident was under legal protection. 
The research protocol was conducted on the study site 
exclusively by the same person (CC) who had good expe-
rience with residents and could give them the necessary 
time and support before, during and after the research 
protocol.
The recruitment of residents was first carried out with 
the help of the health care teams. They drew up an initial 
list of residents likely to be able and willing to respond to 
the questionnaire and according to the inclusion/exclu-
sion criteria. The residents’ medical and administrative 
records were consulted to confirm the caregivers’ indi-
cations for Alzheimer disease (or related disorders) and 
collect the sociodemographic information. The data was 
then made anonymous.
Residents were informed of the study and individually 
invited to participate of their own free will in the research 
by asking for their agreement and when and at what 
time they wished to answer the questions. Before the 
interview, a simplified and large-print information and 
consent form was presented to residents explaining the 
aim of the research, the approximate duration, and data 
confidentiality and anonymity for aggregate results for 
scientific publication with a poster feedback of the sim-
plified results that would be offered to them. They were 
also informed that they could stop the interview at any 
time and stop it permanently or resume it later if they so 
wished. Finally, we obtained their written consent signed 
in duplicate, one copy of which was given to the resident. 
The interview took place in their rooms.
The data collection was conducted from January to 
February 2020 before the Covid-19 pandemic and subse-
quent lockdowns.
Statistical analysis
Descriptive statistics Descriptive statistics were pre-
sented as percentages, mean (± SD)/Range, age, type of 
dementia, MMSE score, gender, marital status, educa-
tional status, and GIR (level de dependency).
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Acceptability At first, the QoL-AD NH acceptability was 
assessed by the number of refusals and current dropouts 
and then by the percentage of missing data (rate of com-
pleted items) [53]. Floor and ceiling effect were analysed 
with a permissible limit of 15% [43]. Lastly, the adminis-
tration time was calculated.
Normality test Variables were assessed for univariate 
and multivariate normality. For skewness, if data were 
greater than + 1 or lower than -1 and for kurtosis data 
were greater than + 1, then data distribution essentially 
deviated from a normal distribution [54]. Multivariate 
normality for QoL-AD NH was evaluated using the Mar-
dia test with a critical ratio below 8.00, indicating mul-
tivariate normality [55]. To identify univariate outliers, 
the variables were standardised. The cases with values 
exceeding 3.29 were considered outliers [56]. To evaluate 
multivariate outliers, the values of "Mahalanobis distance" 
were generated. The presence of possible outliers moving 
away from "centroids" and whose Mahalanobis D2 values 
were lower than 0.001 were considered multivariate outli-
ers [56].
Factor analysis We followed a two-step approach based 
on exploratory structural equation modeling (ESEM) [57]. 
ESEM can be seen as a compromise between the flexibil-
ity of EFA and the rigour of SEM [58]. While its applica-
tion lies mainly in confirmatory research, ESEM has been 
used when factor structures were not yet well established 
[59, 60]. First, exploratory factor analysis (EFA) was con-
ducted to determine factor loadings. The resulting load-
ing matrix was then used to formulate a structural equa-
tion model (SEM), allowing for a more detailed model fit 
assessment.
Parallel Analysis (PA) was used to determine the opti-
mal factors to extract [61]. We simulated 1000 random 
datasets. In addition to the model proposed by the paral-
lel analysis, we fitted different EFA models that assumed 
one, two, or three factors. Fit indices of these models 
were compared in the ESEM step.
Exploratory factor analyses were conducted using max-
imum likelihood estimation and goemin rotation and an 
epsilon value of 0.50 [57, 62]. Geomin is an oblique rota-
tion method, so the extracted factors could be correlated.
Once all EFA models were fit, ESEM was performed 
using their implied loading matrices. As mentioned 
above, ESEM was used to provide further guidance for 
selecting an adequate factor structure [63]. As cut-off cri-
teria for good model fit, we mainly used the values pro-
vided by Hu and Bentler [64]: a model will be accepted 
if the Tucker-Lewis Index (TLI) surpasses 0.94 and the 
standardised root mean square residual (SRMR) is below 
0.09.
Three criteria were taken into account to choose a 
model from our exploratory analysis: the interpretability 
of the factors, the model’s simplicity, and the fit indices.
Measurement invariance Measurement invariance was 
tested between three age groups: persons of 60 to 84 years 
of age (n = 50), 84 to 90 years (n = 60), and 90 to 100 years 
(n = 64). Measurement invariance was also tested between 
two groups by cognitive level (MMSE) with similar sizes: 
residents with MMSE scores below the median value (19), 
n = 90, and residents with MMSE scores above than the 
median value, n = 84.
We estimated a series of models with increasing equal-
ity constraints. The decline in model fit could easily be 
examined. If the difference in model fit after increasing 
constraints decreased too much, it could be concluded 
that measurement invariance did not hold. Following the 
cut-off scores proposed by Cheung and Rensvold [65], 
measurement invariance does not hold if the CFI drops 
by more than 0.01.
Convergent and  divergent validity Convergent validity 
was assessed using Spearman’s Rhô correlation compar-
ing the QoL-AD NH with the DQoL. Divergent valid-
ity was also assessed using Spearman’s Rhô correla-
tion, comparing the QoL-AD NH with the GDS-15. We 
retained the following values: weak (ρ < 0.25), moder-
ate (0.25 < ρ < 0.50), good (0.50 < ρ < 0.75), and excellent 
(ρ > 0.75) [66]. We formulated four hypotheses inferred 
from the literature: 1) The total score of the QoL-AD NH 
would correlate positively and moderately with the scores 
of the four positive dimensions of the DQoL scale. 2) (If 
multifactor solution) The scores of the retained factors of 
the QoL-AD NH would correlate positively and moder-
ately with the scores of the four positive dimensions of the 
DQoL scale. 3) The total score of the QoL-AD NH would 
correlate negatively and well with the score of the GDS-
15. 4) (If multifactor solution) The scores of the retained 
factors of the QoL-AD NH would correlate negatively and 
well/moderately with the score of the GDS-15. Conver-
gent and divergent validity were confirmed if at least 75% 
of the results corresponded with the hypotheses [43].
Known-group validity The objective was to discriminate 
across groups known to differ theoretically [67]: residents 
with cognitive impairment and those without. Known-
group validity was evaluated using an Independent 
Samples t-Test to test QoL scores between two groups. 
Secondly, a one-way ANOVA followed by a post hoc Bon-
ferroni test to assess QoL scores between three groups 
(residents without cognitive impairment, mild cognitive 
impairment and moderate cognitive impairment). Based 
on the literature, we hypothesised that the group with 
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dementia would have significantly lower scores of QoL 
than the residents without cognitive impairment. We 
also assumed that there would be a significant difference 
in QoL scores between the three groups (without, mild 
and moderate dementia). Known-group validity was con-
firmed if at least 75% of the results corresponded with the 
hypotheses [43].
Reliability analysis Internal consistency. Internal con-
sistency was assessed with Cronbach’s alpha. We used 
Kline’s Cut-offs with coefficients around 0.90 considered 
“excellent,” values around 0.80 as “very good,” and values 
from 0.70 as “adequate” [68].
McDonald’s total omega, hierarchical omega, and hier-
archical subscales. In multidimensionality, Cronbach’s 
alpha values often underestimate the reliability of scales 
[69]. Coefficient omega [70] allows to model sources of 
variance at general and multidimensional levels and 
is the more suitable estimate of reliability in the case 
of hypothesised multidimensionality [69, 71–73]. The 
bifactor model with the general QoL factor and multi-
dimensional factor (factors determined by EFA/ESEM) 
was used to estimate omega values [69, 73, 74]. Three 
different omega values (total, hierarchical, and hierar-
chical subscales) were estimated to examine the factor 
solution received at EFA/ESEM stage. Total omega was 
estimated for the overall scale and three subscales. Total 
omega values above 0.70 indicate an acceptable level of 
composite reliability [75]. Hierarchical omega shows the 
proportion of variance attributable to a general factor 
[69]. There is no commonly accepted cut-off for hierar-
chical omega. A value above 0.50 is recommended as a 
low-level hierarchical omega, indicating that the scale is 
a valid instrument to measure a general factor [71]. The 
hierarchical omega subscale indicates the proportion of 
subscale scores variance explained by the multidimen-
sional (subscale) factor after controlling for the effect 
of the general factor [76]. The value of the hierarchical 
omega subscale above 0.50 is considered enough for the 
reliability of a subscale [71].
Test–retest analysis. Test–retest reliability was assessed 
in a two-week interval in a group of twenty-five resi-
dents with mild to moderate cognitive impairment. In 
order to compare results with previous studies, we used 
both Pearson’s correlation and the Intraclass Correlation 
Coefficient of type ICC (3,1) with a 2-way mixed-effects 
model, single measurement, unique rater and absolute 
agreement. It was based on the following values: less than 
0.50 (poor), between 0.50 and 0.75 (moderate), between 
0.75 and 0.90 (good), and above 0.90 (excellent) [77].
All statistical analyses were done using R version 4.1.0 
(2021–05-18) – "Camp Pontanezen", Brest, France [78] 
and the integrated development environment RStudio 
1.4.1103 [79].
Results
Phase 1: Translation and cross‑cultural adaptation 
of the QoL‑AD NH French participant version
During the cross-cultural adaptation phase with the 
expert committee, some items had to be adapted, includ-
ing item 09 “Personality overall” whose translation into 
“Self-image” was maintained (similar to the validated 
13-item French version) [31]. Also, item 12 “Life overall” 
was adapted to “Current life in general” to clearly distin-
guish the desired meaning of current quality of life from 
life satisfaction. The supplementary document contain-
ing the instructions and scale questions for each item was 
also adapted. A pre-final version was developed and then 
pre-tested with twelve residents suffering from mild to 
moderate cognitive impairment who were not part of the 
sample for psychometric validation. This pre-final ver-
sion proved to be well adapted and required only a few 
explanations for the item 09 “Self-image” and the item 
15 “Ability to make choices in one’s life” with a slight 
rewording of the phrasing of the questions in the inter-
view guide.
Phase 2: Psychometric properties of the French QoL‑AD NH 
French Participant version
Descriptive statistics
Of the twenty-one nursing homes contacted, seven 
agreed to participate, i.e. 1/3 of them. Four were private 
structures, and three were associations. The size and 
capacity of these structures varied from 35 to 90 resi-
dents. A total of one hundred and seventy-four residents 
with mild to moderate cognitive impairment partici-
pated in the research (Table 1) and a comparison group 
of thirty-three residents without cognitive impairment 
joined the study only to test known-group validity. Both 
groups had equivalent socio-demographic characteristics 
but the comparison group did not suffer from any cog-
nitive impairment, with an average MMSE score of 26 
(± 2.6) on a scale of 24 to 30.
Acceptability
All invited participants accepted to participate and com-
pleted the protocol. The completion rate was 99.6% for 
the QoL-AD NH. No floor (0%) or ceiling effect (0%) was 
identified for the QoL-AD NH. With the presentation of 
the scale and the instructions, the average time taken to 
complete this questionnaire was 11 min.
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Normality test
The Skewness of two items (item 4 & item 6) were just 
above -1. As a result, these variables were not normally 
distributed because there were negatively skewed. A cor-
rection log10(max(x + 1) − x) was applied to try to cor-
rect negatively skewed data with success. If the QoL-AD 
NH continuous variables were normally distributed, con-
tinuous variables from the GDS-15 and the dimension 
“Feeling of belonging” of the DQoL were not. The critical 
ratio of the Mardia test was 7.84, so there was multivari-
ate normality [55]. There was no univariate or multivari-
ate outlier [56].
Factor structure
Item 12 “Current life in general” was not included in the 
factor analysis because it was the general item of the scale 
and was identical to the Dementia Quality of Life Scale 
item that was not part of the factor structure but as an 
item evaluating and generally summarising the perceived 
QoL [16, 39]. Also, as it is a QoL in Alzheimer’s disease 
scale, only the 174 residents with Alzheimer’s disease 
or related disorders from mild to moderated cognitive 
impairment were included in factor analysis.
Parallel Analysis (PA) A parallel analysis was conducted. 
Finally, four factors were suggested for exploratory factor 
analysis.
Exploratory Factor Analysis (EFA) The Kaiser–
Meyer–Olkin measure of sampling adequacy (KMO) 
was 0.84 and Bartlett’s test for sphericity was significant 
(χ2(91) = 699.34, p < 0.001), so we proceeded with the fac-
tor analysis. Four EFA models (models 1 to 4) with one to 
four factors were examined. Their goodness-of-fit statis-
tics are displayed in Table 2.
Exploratory Structural Equation Modeling (ESEM) The 
results showed that the one-factor and two-factor models 
did not fit. Only the three-factor and four-factor models 
had good fit indices (Table 2).
The four-factor model adjusted too much to the data 
indicating probable overfitting. Moreover, two of the 
four factors were based on only two items, and one of the 
other factors was difficult to interpret (Additional file 4). 
On the contrary, the three-factor model was easy inter-
pretable, simple and a good fit to data. As a result, this 
Table 1 Description of nursing home residents with Alzheimer’s 
disease or related disorders (n = 174)
* GIR level of dependency from GIR 1 (the most dependant) to GIR 6 (the least 
dependant)
N % Mean (± SD)/Range
Age in years 174 100.0 86.6 (± 7.6)/60–100
 60–69 9 5.2
 70–79 16 9.2
 80–89 75 43.1
 90–100 74 42.5
Type of probable dementia 174 100.0
 Alzheimer’s disease 138 79.3
 Mixed dementia 24 13.8
 Vascular dementia 12 6.9
MMSE score
 Total score 174 100.0 18.8 (± 5.1)/10–26
 < 19 78 81.6 13.9 (± 6.6)/10–18
 ≥ 19 96 18.4 22.7 (± 2.3)/19–26
Gender
 Female 142 81.6
 Male 32 18.4
Marital status
 Single 54 31.1
 Married 11 6.3
 Divorced 4 2.3
 Widowed 105 60.3
Educational status
 No qualification 46 26.4
 Primary diploma 80 46.0
 Secondary 29 16.7
 Higher education 19 10.9
GIR*
 GIR 1 1 0.6
 GIR 2 39 22.4
 GIR 3 41 23.6
 GIR 4 72 41.3
 GIR 5 16 9.2
 GIR 6 5 2.9
Table 2 Comparison of the four models by their fit indices
Χ2, chi-square; df, degrees of freedom; CFI, comparative fit index; RMSEA, root mean square error of approximation; TLI, Tucker–Lewis index; SRMR, standardised root 
mean square residual
χ2 df p CFI RMSEA TLI SRMR
One factor 193.52 90 0.000 0.821 0.085 0.819 0.082
Two factors 143.13 88 0.000 0.905 0.062 0.902 0.068
Three factors 88.50 85 0.390 0.995 0.015 0.994 0.051
Four factors 56.60 81 0.982 1.000 0.000 1.047 0.042
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three-dimensional model was chosen. Standardised fac-
tor loadings of this model are summarised in Table 3.
The three factors were interpreted as follows: Factor 
1: “Intrapersonal & interpersonal environment-related 
QoL”; Factor 2: “Self-functioning-related QoL”; Factor 3: 
“Perceived current health-related QoL” (Table 3).
Measurement invariance (MI) of the selected model
Measurement invariance analysis by age group showed 
no significant drop in model fit. We observed a compara-
tive fit index (CFI) of 0.889 for the configural invariance 
model which remained constant in the metric invariance 
model. Finally, a drop of 0.003 was observed in the scalar 
invariance model [65]. It was concluded that the three-
factor model was measurement invariant by age group 
(Table 4).
Regarding measurement invariance by mental state, we 
did not observe decreasing CFA and increasing RMSEA 
when comparing models. Also, fit CFA and RMSEA 
values indicated an acceptable fit for configural and 
constrained models [65]. Thus, the 3-factor model dem-
onstrated measurement invariance across groups with 
lower and higher MMSE scores (Table 5).
Convergent validity
The results showed that the QoL-AD NH Total score 
correlated positively and well/moderately with the four 
positive dimensions of the DQoL, “Sense of aesthetics” 
(ρ = 0.44, p < 0.01), “Positive affect” (ρ = 0.51, p < 0.01), 
“Feeling of belonging” (ρ = 0.46, p < 0.01), “Self-esteem” 
(ρ = 0.53, p < 0.01) thus confirming the hypothesis. More-
over, the three factors of the QoL-AD NH correlated 
positively with the four positive dimensions of the DQoL: 
Factor 1 score “Intrapersonal & interpersonal environ-
ment-related QoL” correlated positively and moderately/
well with the four positive dimensions of the DQoL, 
“Sense of aesthetics” (ρ = 0.42, p < 0.01), “Positive affect” 
(ρ = 0.52, p < 0.01), “Feeling of belonging” (ρ = 0.49, 
p < 0.01), “Self-esteem” (ρ = 0.43, p < 0.01) confirming 
the hypothesis; Factor 2 score “Self-functioning-related 
QoL” correlated positively and moderately with the four 
positive dimensions of the DQoL, “Sense of aesthetics” 
(ρ = 0.38, p < 0.01), “Positive affect” (ρ = 0.39, p < 0.01), 
“Feeling of belonging” (ρ = 0.30, p < 0.01), “Self-esteem” 
(ρ = 0.43, p < 0.01) confirming the hypothesis; Factor 3 
score “Perceived current health-related QoL” correlated 
positively and moderately/weakly with the four positive 
dimensions of the DQoL, “Sense of aesthetics” (ρ = 0.25, 
p < 0.05), “Positive affect” (ρ = 0.22, p < 0.05), “Feeling of 
belonging” (ρ = 0.24, p < 0.05), “Self-esteem” (ρ = 0.42, 
p < 0.01) partially confirming the hypothesis (Additional 
file 1: Table S1). These results revealed acceptable conver-
gent validity [43].
Divergent validity
The QoL-AD NH total score was highly and negatively cor-
related with the GDS-15 scale score (ρ = -0.57, p < 0.01), 
confirming the hypothesis. Moreover, the GDS-15 score 
correlated negatively and moderately with the three fac-
tors of the QoL-AD NH: with Factor 1 score “Intrapersonal 
Table 3 Standardised factor loadings, eigenvalues, factor 
intercorrelations, and variance explained for 3-factor model
Bold numbers represent the most appropriate items corresponding to each 
factor, as indicated by their maximum factor loading
Item Factor 1 Factor 2 Factor 3
Physical health − 0.02 0.02 0.89
Vitality 0.09 0.10 0.53
Moral/mood 0.50 − 0.03 0.27
Living environment 0.63 0.07 − 0.09
Memory 0.12 0.35 0.01
Relationship with family 0.44 − 0.07 0.00
Relationship with staff 0.63 − 0.17 0.08
Relationship with friends 0.46 0.18 − 0.07
Self-image 0.38 0.16 0.16
Keep busy 0.02 0.69 0.08
Do things for pleasure − 0.04 0.68 0.12
Self-care 0.36 0.13 0.15
Live with others 0.43 0.21 − 0.01
Make choices 0.19 0.58 − 0.07
Eigenvalues 4.79 1.36 1.20
Factor intercorrelations
 Factor 1 –
 Factor 2 0.47 –
 Factor 3 0.38 0.41 –
Variance explained 16% 13% 12%
Table 4 Measurement invariance across age groups
cfi.robust rmsea.robust
Configural 0.889 0.073
Metric invariance 0.889 0.073
Scalar invariance 0.885 0.071




Metric invariance 0.922 0.059
Scalar invariance 0.928 0.055
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& interpersonal environment-related QoL” (ρ = -0.48, 
p < 0.01), with Factor 2 score “Self-functioning-related QoL” 
(ρ = -0.45, p < 0.01) and with Factor 3 score “Perceived cur-
rent health-related QoL” (ρ = -0.43, p < 0.01) partially con-
firming the hypothesis (Additional file 1: Table S1). These 
results revealed acceptable divergent validity [43].
Known‑group validity
First of all, we compared two groups: residents without 
cognitive impairment (n = 33) and the whole group of res-
idents with cognitive impairment (n = 174). As predicted, 
QoL of the residents with cognitive impairment was sig-
nificantly lower (37.4 ± 6.2) than the QoL of residents 
without cognitive impairment (40.5 ± 5.2), t(205) = 2.70, 
p = 0.007, thus confirming the hypothesis. Secondly, 
we compared the three groups of residents’ QoL: resi-
dents with mild dementia (n = 96), moderate dementia 
(n = 78) and without cognitive impairment (n = 33). The 
results revealed a significant difference between groups 
determined by the one-way ANOVA, F(2,204) = 4.871, 
p = 0.009. A Bonferroni post hoc test showed that the 
residents’ QoL with moderate cognitive impairment was 
significantly lower (36.7 ± 6.2, p = 0.006) than the QoL of 
residents without cognitive impairment (40.5 ± 5.2). How-
ever, there was no significant difference between the QoL 
of residents with moderate cognitive impairment and the 
residents with mild cognitive impairment (p = 0.379) and 
between the residents with mild cognitive impairment 
and residents without cognitive impairment (p = 0.129). 
As a result, the hypothesis was partly confirmed. Globally, 
these results confirmed good known-group validity [43]. 
Finally, we resumed means and standard deviations for 
each group’s continuous variables (Additional file 2) and 
each QoL-AD NH scale item (Additional file 3).
Reliability analysis
Internal consistency Cronbach’s alpha for all 15 items 
of the QoL-AD NH was α = 0.86. So, the internal con-
sistency of the total scale was very good [68]. Once the 
three-factor model was selected after factor analysis and 
ESEM, we measured internal consistency for the subscales 
(Table  6). The results showed that the Cronbach’s alpha 
was very good for Factor 1 (“Intrapersonal & interpersonal 
environment-related QoL”, α = 0.77), adequate for Factor 
2 and Factor 3 (“Self-functioning-related QoL”, α = 0.72; 
“Perceived current health-related QoL”, α = 0.71) [68].
McDonald’s total omega, hierarchical omega, and hierar-
chical subscales (Table 6) In the 3-factor QoL-AD NH 
scale, total omega values were high for both the total scale 
and subscale scores: 0.91 (Total scale), 0.89 (“Intrapersonal 
& interpersonal environment-related QoL”), 0.84 (“Self-
functioning-related QoL”), and 0.74 (“Perceived current 
health-related QoL”). All total omega values exceeded 
the threshold 0.70 [75], supporting composite reliability 
of the scale in general and each of three subscales. The 
hierarchical omega was 0.50. When compared to the total 
omega value of 0.91, it is clear that the explained variance 
in the total QoL scores is attributable in approximately 
equal proportions to the general QoL factor (around 
55%) and multidimensionality factor (around 45%). It 
indicates that raw QoL scores were essentially affected 
by the subscale factor supporting the multidimensional-
ity of the QoL scale. Omega hierarchical subscale values 
exceeded the minimal level 0.50 [71] for “Intrapersonal & 
interpersonal environment-related QoL” (0.60) and “Self-
functioning-related QoL” (0.58) subscales, indicating that 
the majority of subscale score variance was attributable 
to the multidimensional factor even after the removing 
effect of the general factor. The multidimensional factor 
contributed 67% and 69% in the total explained variance 
of subscale scores, indicating that the majority of reli-
able variance of these subscale scores was independent of 
the general factor. Hierarchical omega for the third fac-
tor “Perceived current health-related QoL” was 0.34, that 
was lower than the level 0.50. However, comparing this 
score with the total omega score of this subscale, 0.74, it 
indicates that the subscale factor contributed significantly 
(46%) to the total explained variance of subscale scores 
after controlling for the general factor.
Test–retest analysis Finally, test–retest reliability was 
calculated by the Pearson’s correlation coefficient and the 
ICC (3,1). The results revealed good test–retest reliability 
at 15-day intervals, with r(23) = 0.89, p = 0.01, and ICC 
(3,1) = 0.76, p = 0.001 [77].
Discussion
We aimed to provide a cross-cultural adaptation in 
French and the first psychometric validation of the QoL 
in Alzheimer’s Disease Nursing Home Scale—Participant 
Table 6 Cronbach’s alpha and McDonald’s total omega, 
hierarchical omega and hierarchical subscales for the three-factor 
model
α = alpha, ωs(ω) − ωs = total omega for subscales and total ω for total scale, 
ωhs = omega hierarchical for subscales, ωh = omega hierarchical for general 
factor (general factor is a latent factor of QoL)
α ωs(ω) ωhs(ωh)
F1 “Intraperso. & interperso. environment-related 
QoL”
0.77 0.89 0.60
F2 “Self-functioning-related QoL” 0.72 0.84 0.58
F3 “Perceived current health-related QoL” 0.71 0.74 0.34
QoL total scale 0.86 (0.91) (0.50)
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version. To our knowledge, there was no specific scale 
to assess QoL in Alzheimer’s disease for French-speak-
ing residents in nursing homes. Moreover, the QoL-AD 
NH had not been thoroughly analysed, even in its origi-
nal English language. Our global results show that after 
the cross-cultural process and study validation, the 
French adaptation of the QoL-AD NH Participant ver-
sion has globally good psychometric properties with a 
three-dimensional factor structure (invariant across age 
and mental status groups), acceptable convergent and 
divergent validity, good known-group validity, adequate 
internal consistency/omega values and good test–retest 
reliability.
Interpretation of the results and comparison 
with the literature
Since the psychometric qualities of QoL-AD NH have 
not been widely explored, we did not have sufficient 
theoretical elements to perform a Confirmatory Factor 
Analysis (CFA). To analyse the factor structure, we used 
both EFA and ESEM. The use of the ESEM combined the 
advantages of EFA and CFA and allowed us to select the 
most appropriate model while remaining in an explora-
tory design.
We finally retained the three-factor model, which was, 
at the same time, interpretable, simple and a good fit to 
data: Factor 1 “Intrapersonal & interpersonal environ-
ment-related QoL” (8 items); Factor 2 “Self-functioning-
related QoL” (4 items); and Factor 3 “Perceived current 
health-related QoL” (2 items). These three factors seem to 
be representative of and pertinent to the resident’s QoL in 
Alzheimer’s disease in nursing homes. Indeed, for Factor 
1, relationships are essential for nursing home residents, 
especially with their families [80–82]. The more objec-
tive living environment also plays a vital role in residents’ 
QoL with cognitive disorders, mainly when adapted to 
their disability and facilitates their taking temporospatial 
bearings [9, 81, 83]. About the “Self-functioning-related 
QoL” factor, it is very relevant as the resident can feel that 
he or she is still able to make choices, that he or she is 
given a choice, especially in daily activities [80, 82, 84]; 
this is what the person-centred care and the Montessori 
approach applied to the elderly advocate [85–87]. Finally, 
it is not surprising to find a perceived health factor in a 
health-related quality of life scale that usually contains 
physical and mental health measures with other elements 
not directly related to health [53, 88]. This factor is based 
on only two items. However, some health-related quality 
of life scales can have 2-item factors [89–91], and we dis-
cuss their reliability further. Perceived health has always 
been important, regardless of the person’s age and level 
of cognitive impairment [80, 92]. Moreover, the phenom-
enon of anosognosia may allow some residents to be not 
fully aware of their state of health; this may be a protector 
as they often report having good physical health/vitality 
and good QoL [93–95].
Our results contrast to the initial Edelman’s study that 
showed a unique factor structure [13]. Indeed, in our 
study, the three-factor solution supports the multidimen-
sionality of the concept of QoL in Alzheimer’s disease as 
evoked by Lawton’s model, including both objective and 
subjective factors [9]. Our findings also seem consistent 
with the Spanish validation led in day centres containing 
11 of the 15 items of the QoL-AD NH, which revealed 
the same three-factor structure in the EFA step [27]. 
Nevertheless, after CFA, they decided to retain a two-
factor solution even if the three-factor model fitted well 
[96]. Moreover, as in the Spanish study, we did not find 
the “Psychological well-being” factor evoked in a few 
validation studies of the QoL-AD 13 [97, 98]. However, 
our results are consistent with an Australian study con-
ducted in long-term care facilities, revealing an identical 
three-factor structure [39]. This study aimed to extract a 
new classification system for economic evaluation from 
the QoL-AD NH factor structure. Based on 11 of the 15 
items in the QoL-AD NH, an EFA and then a CFA con-
firmed a three-factor model.
Our factor analysis contained 14 of the 15 items due to 
excluding the global QoL item (item 12), as other studies 
have done [16, 39]. However, a few items loaded a bit low 
but were acceptable for an EFA and ESEM as they loaded 
at least 0.35, in agreement with previous studies and a 
part of the literature admitting a threshold of 0.30 or 0.32 
[39, 56, 99, 100]. Moreover, there was no cross-loading 
because the difference between the highest loading and 
the second-highest loading for all items was greater than 
0.20 [101]. For example, item 05 “Memory”, was identi-
fied in the literature as a low loading item [23, 27, 39, 97]. 
However, this item is essential to the scale because it is 
specific to Alzheimer’s disease (or related disorders) and 
probably more critical for a proxy evaluation of anosog-
nosia. In that sense, we wanted to keep all the items on 
the one hand because the factorial results were only valid 
for our exploratory sample. Conversely, further studies 
are to be carried out to validate the hetero-evaluation 
version and compare the two versions. Indeed, in its 
original version, the author advocates calculating a com-
posite score that would consist of 2/3 of the score on the 
resident’s evaluation and 1/3 on the hetero-evaluation. In 
addition, as discussed below in the clinical recommen-
dations, the individual consideration of items to assess 
change in the QoL would be of clinical significance and 
should be taken into account.
When we examined convergent validity, we found sig-
nificant positive and moderate correlations between the 
QoL-AD NH and the DQoL. This may suggest that the 
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QoL-AD NH captures further information, which is not 
included by the DQoL that is not specific to older people 
who live in a nursing home. However, the literature con-
sistently showed significant but moderate positive cor-
relations (i.e. around 0.30-0.63) between the QoL-AD 13 
(from which QoL-AD NH derives) total score and the 
dimensions of the DQoL [29, 32, 102]. Also, when we 
examined the correlations between the three extracted 
factors from the QoL-AD NH and the four positive fac-
tors of the DQoL (Additional file  1), we found that the 
weakest correlations between the two scales lay between 
the “Perceived current health-related QoL” factor of the 
QoL-AD NH and the different factors of the DQoL. The 
perceived health factor that is based on 2 items may affect 
the correlation. However, this may be because the DQoL 
scale is considered as a needs assessment tool rather than 
an HRQoL tool [48]. The question arises as to whether the 
QoL-AD NH itself can be regarded as a purely HRQoL 
scale [39] when it originally seemed to inherit Lawton’s 
model. While the QoL-AD was also classified as a Patient-
Reported Outcome Measures (PROMs), the vast majority 
of the tools used in studies were proxy scales [103]. Con-
cerning divergent validity, the factor “Perceived current 
health-related QoL” is the factor that correlates least with 
depression, with, even so, a moderately strong correla-
tion. Our findings are similar to previous studies; there 
is a negative and significant relationship between QoL 
measured by the QoL-AD and depression [23, 26, 30]. 
Only one German study reports no relationship between 
QoL and depression [29]. However, many studies have 
shown that depression was one of QoL’s strongest predic-
tors in Alzheimer’s disease [21, 25, 33, 36]. We concluded 
that the convergent and divergent validities were globally 
aligned with the other studies and acceptable.
The results of known-group validity showed that the 
group of residents with cognitive impairment had signifi-
cantly lower QoL scores than the residents without cog-
nitive impairment. These results agree well with existing 
studies [26, 104]. However, taking into account the three 
groups of residents (without, mild and moderate cogni-
tive impairment), the results showed that there was a sig-
nificative difference in the QoL only between the group 
of residents without cognitive impairment and the group 
with moderate cognitive impairment, and therefore not 
with the group with mild cognitive impairment. This 
result may be due to the MMSE cut-off utilised to differ-
entiate between groups, as we discuss further.
The question of whether the QoL-AD NH scale can 
also be used to assess QoL for residents without cognitive 
disorders is relevant. One study revealed the factor struc-
ture and measurement invariance of the QoL-AD 13 with 
a non-cognitive impairment community-dwelling sample 
[97]. This study showed a three-factor solution, including 
“Physical well-being”, “Social well-being” and “Psycholog-
ical well-being”. Our study did not extract the factor “Psy-
chological well-being” and we had only 9 common items 
in the scale; it is difficult to compare the results since it is 
not quite the same scale nor the same sample. However, 
we think the QoL-AD-NH could be used to assess QoL of 
residents without cognitive impairment, even if elements 
are necessarily missing in the QoL, such as spirituality 
that can be important for residents who do not have cog-
nitive disorders [10, 48].
Lawton’s model, the most widely used theoretical model 
for conceptualising QoL in Alzheimer’s disease, is not spe-
cific to Alzheimer’s QoL for people living in an institution 
but more generally to QoL in Alzheimer’s disease. How-
ever, this model takes into account the objective environ-
ment, such as the living environment. In that sense, the 
institutional living environment in the EHPAD nursing 
home probably plays an essential role in the residents’ QoL, 
beyond purely subjective factors. In our study, item 04 “Liv-
ing environment” was the strongest explanatory component 
of factor 1 which itself was the factor explaining most of the 
variance of QoL-AD NH. While Lawton’s model is still the 
most important conceptualisation of QoL in Alzheimer’s 
disease, it would be appropriate to develop a more specific 
theoretical and conceptual framework of QoL in Alzhei-
mer’s disease in institutions, mainly in nursing homes.
Regarding the reliability of the QoL-AD NH, internal 
consistency was very good for the total scale and one sub-
scale, adequate for the two others. Test–retest revealed a 
good ICC. These results are in line with other studies [13, 
26, 27, 31]. Going further than Cronbach’s alpha by testing 
all McDonald’s omega values, the global results confirmed 
the reliability of the subscales. Testing McDonald’s hierar-
chical omega subscales, two subscales (“Intrapersonal & 
interpersonal environment-related QoL” and “Self-func-
tioning-related QoL”) showed good reliability, contributing 
to subscale score variance irrespective of the general QoL 
factor (latent factor) influence. The third subscale “Per-
ceived current health-related QoL”, had a less independ-
ent individual effect on subscale score variance than the 
general QoL factor (46% vs 64%). However, this effect is 
essential to consider that “Perceived current health-related 
QoL” is a reliable measure of the corresponding dimension 
of QoL. On the other hand, it indicates that this subscale 
requires future improvements, perhaps more items to 
increase reliability and, at the same time, validity.
Strengths and limitations
In our study, the number of participants was more 
extensive than similar validation studies [26, 27, 29, 
96]. Moreover, our psychometric validation went fur-
ther than just EFA, using the ESEM method that com-
bines the strengths of EFA and CFA while remaining an 
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exploratory process. We also went beyond Cronbach’s 
alpha by testing all MacDonald’s omega coefficients, 
including the omega hierarchical subscale. To our knowl-
edge, this study is the first to examine the full validity 
and reliability of the QoL-AD NH, as the original ver-
sion was never validated psychometrically. This study 
is also the first step towards the French adaptation and 
validation of a self-report scale that measures the QoL of 
nursing home residents with mild to moderate cognitive 
impairment.
Some study limitations should be acknowledged. First 
of all, we used EFA and ESEM on the same dataset; there 
may be a potential danger of overfitting [105]. However, 
we used ESEM to provide further guidance for selecting 
an adequate factor structure by staying in an exploratory 
design. Confirmatory studies will need to be conducted 
on another dataset. Secondly, it was difficult to determine 
a cut-off between mild and moderate cognitive impair-
ment. The use of Folstein’s MMSE score as a criterion of 
categorisation between mild and cognitive impairment 
could have been combined with the Clinical Dementia 
Rate (CDR) scale [38] or the Global Deterioration Scale to 
refine the level of severity and cut-off in dementia. How-
ever, these scales were not validated in French. Thirdly, 
the measurement invariance results across age and men-
tal state should be interpreted with caution as the sam-
ple size to test measurement invariance was small. This 
is the reason why we did not use measurement invari-
ance as a criterion for selecting the factor model. Other 
studies could use measurement invariance as a criterion 
for selecting a factor model in ESEM if they have a suf-
ficiently large number of participants. Lastly, Factor 3 
“Perceived current health-related QoL” was composed of 
only two items and, although valid and reliable, could be 
reworked by adding a few items that could improve it.
Future research and clinical recommendations
First of all, further research will have to carry out con-
firmatory factor analysis (CFA) of the QoL-AD NH and 
assess the proxy-report version’s psychometric proper-
ties, adding validity and reliability to QoL-AD NH by 
comparing the self-report (during an interview) and 
proxy-report versions (by staff).
Researchers have long considered QoL as a secondary 
outcome in studies. However, QoL might, and should 
become, the principal outcome of interest in the coming 
years in nursing homes. There is a need to develop longi-
tudinal studies and use repeated measures that are essen-
tial to assess sensitivity to change and responsiveness. 
However, we know the difficulty of QoL instruments in 
assessing significant changes in QoL measures. That is 
why from a clinical perspective and in agreement with 
Tractenberg and colleagues who compared the change in 
the measures of the QoL-AD 13, we think it is possible to 
leave the items of the QoL-AD NH as the individual QoL 
components to qualify the direction and quantification of 
this change [106]. For these researchers, accounting for 
change at the item level could provide more robust evi-
dence of change in the QoL, including its improvement.
In this direction, it would be advisable to study and 
consider the “Response shift” phenomena. This change 
in response over time would consist of a change in inter-
nal standards (e.g. re-calibration), values (e.g. re-prioriti-
sation) and reconceptualisation of what QoL can be like 
[107]. As a result, residents may perceive and interpret 
the questions put to them differently over time, depend-
ing on the course of their illness, in terms of meaning, 
priorities and impact on their personal life. While the 
response shift has been studied and taken into account 
with other HRQoL scales, it has never been studied in 
Alzheimer’s disease. Consequently, other studies could 
try to ask the resident for each one of the items if it is 
“very important”, “moderately important” or “not impor-
tant” for them. It would also be interesting to ask the resi-
dent’s opinion for each item and monitor change if it is 
noticed from a clinical perspective.
Also, the QoL-AD NH could constitute a baseline for 
QoL of residents without cognitive impairment before 
the disease symptoms appear [97]. Moreover, after diag-
nosis, the QoL-AD NH could be used to assess the resi-
dent’s QoL and try to improve it, especially after a change 
in treatment or a non-drug intervention. Finally, staff 
could and should use the QoL-AD NH when drawing up 
the resident’s life and care project in a dynamic co-con-
struction approach involving the resident.
Conclusions
The French adaptation of the QoL-AD NH has shown 
globally good psychometric properties in terms of both 
validity and reliability for the Participant version dur-
ing an interview. There is now a specific French scale 
to assess residents’ quality of life with mild to moder-
ate cognitive impairment. However, a CFA and further 
longitudinal studies are needed to evaluate sensitivity 
to change and responsiveness of this scale. Enabling the 
residents with mild to moderate cognitive impairment 
to assess their own QoL is already the first step and 
could be the bridge to build towards a person-centred 
approach, a resident-centred approach in France.
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